Toolkit
Latest project information
HTA - 17/141/05
Brigatinib after crizotinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib [ID1328]
Project title: Brigatinib after crizotinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib [ID1328]
Call to action: 17/141 Batch 58
Research type: Evidence Synthesis
Chief investigator: Dr Edward Griffin
Contractor: University of Exeter
Cost: £101,062.50
Started: April 2018 | Status: Project complete
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research